Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03570606
Other study ID # ROSA01
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date June 13, 2019
Est. completion date June 2026

Study information

Verified date November 2023
Source Ceramisys Ltd
Contact Rebecca Hutchinson
Phone +441142327070
Email b.hutchinson@ceramisys.com
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

This is an observational, prospective, non-randomised, multi-centred post market clinical follow-up study to compile real world clinical data on safety and efficacy of the synthetic bone graft substitutes in a commercial clinical setting in long bone and extremity defects and in spinal fusion procedures.


Recruitment information / eligibility

Status Recruiting
Enrollment 220
Est. completion date June 2026
Est. primary completion date March 2026
Accepts healthy volunteers
Gender All
Age group 18 Years to 80 Years
Eligibility Inclusion Criteria: Long Bone and Extremity Indications: patients requiring bone grafting after post-traumatic or surgically created bone defects afflicting the long bones and extremities. Spine Indication: patients with degenerative disc disease or trauma who require spinal fusion of 1 or more vertebral bodies and where conservative treatment has been unsuccessful. Patients who are willing and capable of providing informed consent, participating in all testing associated with this clinical investigation at an approved clinical investigational center; Exclusion Criteria: Patients who are currently enrolled in another investigational study or registry that would directly interfere with the current study, except when the patient is participating in a mandatory governmental registry, or a purely observational registry with no associated treatments. Each instance should be brought to the attention of the sponsor to determine eligibility. Women of childbearing potential who are, or plan to become, pregnant during the time of the study (method of assessment upon physician's discretion); The subject is unable or not willing to complete follow-up visits and examination for the duration of the study.

Study Design


Related Conditions & MeSH terms


Intervention

Device:
bone graft substitute
orthopaedic or spine bony defects

Locations

Country Name City State
United Kingdom Sandwell and West Birmingham NHS Trust of City Hospital Birmingham
United Kingdom The Royal Orthopaedic Hospital NHS Foundation Trust Birmingham
United Kingdom Doncaster & Bassetlaw Teaching Hospitals NHS Foundation Trust Doncaster South Yorkshire
United Kingdom Northumbria Healthcare NHS Foundation Trust North Shields
United Kingdom Salford Royal NHS Foundation Trust Salford
United Kingdom University Hospitals of North Midlands NHS Trust Stoke-on-Trent
United Kingdom Taunton and Somerset NHS Foundation Trust Taunton

Sponsors (1)

Lead Sponsor Collaborator
Ceramisys Ltd

Country where clinical trial is conducted

United Kingdom, 

Outcome

Type Measure Description Time frame Safety issue
Primary Primary endpoints will be successful radiographic bone repair. Bone formation and material resorption, observable by x-ray/MRI 12 months
See also
  Status Clinical Trial Phase
Completed NCT03076138 - Gene-activated Bone Substitute for Maxillofacial Bone Regeneration N/A
Completed NCT01738113 - Open Versus Closed Kinetic Chain Exercises in Tibial Distraction Osteogenesis by Ilizarov's METHOD Phase 2
Active, not recruiting NCT06312384 - The Influence of 3D Surgical Template on the Contour of Bone Augmentation, in Patient With Labial Alveolar Ridge Defect and Simultaneous Implantation Phase 3
Not yet recruiting NCT05676905 - Prospective Multicenter Observational Study on the Use of NEOCEMENT® for the Treatment of Bone Defects
Active, not recruiting NCT05659069 - Influence of Mandibular Nerve Lateralization on Nutrition and Speech
Recruiting NCT05758623 - Mg-containing Biodegradable Polymer Bone Repair Material N/A